Visi / NASDAQ / SMMT.US

Summit Therapeutics

Summit Therapeutics

Investuok be komisinių

Pirk ir parduok dalines akcijas vos už 1 €

Informacija ir statistika

Dienos intervalas
1 D.−100,00 %
3 MĖN.−100,00 %
1 SAV.−100,00 %
6 MĖN.−100,00 %
1 MĖN.−100,00 %
1 M.−100,00 %
SIMBOLIS
SMMT
RINKA
NASDAQ
ISIN
US86627T1088

Data

Uždara

Pokytis

Pokytis (%)

Atvira

Didelė

Maža

14,29−0,18−1,26 %14,4714,6814,02
14,11−0,83−5,88 %14,9414,9713,81
14,77−0,46−3,11 %15,2315,3414,65
14,84−0,12−0,81 %14,9615,2114,42
15,070,322,12 %14,7515,1014,27
14,86−0,65−4,37 %15,5115,5414,17
15,71−0,98−6,24 %16,6916,8415,17
17,54−0,29−1,65 %17,8318,5017,38
17,410,160,92 %17,2517,8716,32
17,360,150,86 %17,2117,5017,02
17,000,422,47 %16,5817,1115,90
16,620,150,9 %16,4717,3916,13
17,47−0,39−2,23 %17,8617,9617,18
17,891,769,84 %16,1317,9316,13
15,850,050,32 %15,8016,0115,55
16,02−0,88−5,49 %16,9016,9515,55
16,87−0,88−5,22 %17,7517,9416,83
18,14−0,40−2,21 %18,5418,8117,78
18,790,000 %18,7919,0518,43
18,950,573,01 %18,3819,0818,29
18,660,452,41 %18,2119,4118,21
18,080,623,43 %17,4618,1517,06
17,15−0,77−4,49 %17,9218,1416,83
17,850,130,73 %17,7218,1617,23
17,540,543,08 %17,0017,7616,55
16,980,653,83 %16,3317,4216,01
16,110,090,56 %16,0216,8115,14
21,460,512,38 %20,9522,3820,85
20,83−0,44−2,11 %21,2721,2820,55
21,26−0,76−3,57 %22,0222,3921,25
22,120,040,18 %22,0822,5421,81
22,08−0,17−0,77 %22,2522,3521,45
22,27−1,56−7 %23,8324,7222,14
24,58−2,06−8,38 %26,6426,7723,43
26,381,164,4 %25,2229,2324,92
25,120,522,07 %24,6025,4423,75
25,150,562,23 %24,5925,4824,06
24,423,0812,61 %21,3424,5321,26
21,12−0,38−1,8 %21,5022,1821,03
20,850,743,55 %20,1121,0720,10
20,030,432,15 %19,6020,5119,52
19,670,361,83 %19,3119,8819,15
19,310,341,76 %18,9719,5418,94
18,81−1,18−6,27 %19,9920,1018,75
19,220,663,43 %18,5619,3018,38
18,69−0,50−2,68 %19,1919,4418,56
19,380,975,01 %18,4119,8518,40
18,92−0,23−1,22 %19,1519,5918,57
18,961,658,7 %17,3119,0017,28
16,980,120,71 %16,8617,5416,74
16,58−0,82−4,95 %17,4017,5116,39
17,26−0,23−1,33 %17,4918,2417,14
17,942,0111,2 %15,9317,9715,84
15,540,070,45 %15,4716,1315,36
15,60−0,11−0,71 %15,7116,2115,48
15,51−0,13−0,84 %15,6416,2715,38
15,720,332,1 %15,3915,8315,25
15,60−0,06−0,38 %15,6615,8315,41
15,85−0,33−2,08 %16,1816,3315,80
16,170,090,56 %16,0816,4915,71
16,120,422,61 %15,7016,7215,66
15,46−0,51−3,3 %15,9716,1615,45
16,08−0,10−0,62 %16,1816,5416,00
16,330,462,82 %15,8716,6415,87
15,720,724,58 %15,0015,8814,98
15,110,382,51 %14,7315,3414,60
14,94−0,13−0,87 %15,0715,1414,67
15,380,090,59 %15,2915,4114,93
15,11−0,43−2,85 %15,5415,7915,08
16,190,030,19 %16,1616,4015,85
16,590,985,91 %15,6116,6115,58
15,800,080,51 %15,7215,8115,36
15,68−0,52−3,32 %16,2016,5115,65
16,120,342,11 %15,7816,8015,54
16,090,342,11 %15,7516,2715,72
15,940,281,76 %15,6616,2115,66
15,870,201,26 %15,6715,8915,39
15,880,311,95 %15,5716,1615,49
15,680,835,29 %14,8515,9914,85
14,960,211,4 %14,7515,5614,67
14,63−0,68−4,65 %15,3115,3814,58
15,25−0,02−0,13 %15,2715,5114,64
15,250,030,2 %15,2215,7615,03
14,97−0,02−0,13 %14,9915,0814,65
14,990,875,8 %14,1215,1114,04
13,85−0,30−2,17 %14,1514,4113,84
14,42−0,16−1,11 %14,5814,7714,11
14,590,463,15 %14,1314,7614,13
14,06−0,15−1,07 %14,2114,5514,03
14,48−0,72−4,97 %15,2015,2914,43
15,40−0,37−2,4 %15,7716,3815,17
15,64−0,22−1,41 %15,8615,8815,45
15,90−0,64−4,03 %16,5416,6515,89
16,560,281,69 %16,2816,7716,08
16,49−0,65−3,94 %17,1417,5816,47
17,370,472,71 %16,9017,9816,89
16,850,663,92 %16,1917,0215,66
16,06−0,59−3,67 %16,6516,7816,03
17,04−0,22−1,29 %17,2617,4817,02
17,27−0,35−2,03 %17,6217,8617,21
17,650,834,7 %16,8217,7316,76
16,81−0,35−2,08 %17,1617,1616,27
17,04−2,79−16,37 %19,8319,9016,47
19,680,703,56 %18,9820,1918,98
18,830,040,21 %18,7919,2418,54
19,010,030,16 %18,9819,5118,66
18,661,206,43 %17,4619,0017,46
17,44−0,05−0,29 %17,4917,7417,29
17,52−0,23−1,31 %17,7517,7517,30
17,490,130,74 %17,3617,5817,15
17,49−0,26−1,49 %17,7517,8317,42
17,78−0,13−0,73 %17,9118,1517,75
18,14−0,18−0,99 %18,3218,3618,05
18,380,271,47 %18,1118,5217,94
18,120,140,77 %17,9818,2617,71
18,150,301,65 %17,8518,3217,67
17,820,663,7 %17,1617,8917,14
17,04−0,21−1,23 %17,2517,3816,98
17,01−0,64−3,76 %17,6517,8516,99
17,23−0,06−0,35 %17,2917,5116,88
17,38−0,32−1,84 %17,7017,7517,24
17,57−0,42−2,39 %17,9918,0217,40
17,990,140,78 %17,8518,2117,75
17,940,945,24 %17,0018,0816,82
17,02−1,31−7,7 %18,3318,5317,01
18,620,180,97 %18,4418,7318,15
18,31−0,57−3,11 %18,8819,1018,09
18,810,522,76 %18,2918,9818,19
18,370,985,33 %17,3919,0517,35
17,250,060,35 %17,1917,5416,76
17,26−0,28−1,62 %17,5417,8217,25
17,89−0,14−0,78 %18,0318,1717,66
17,820,120,67 %17,7018,0017,45
17,64−0,19−1,08 %17,8317,9217,23
17,841,598,91 %16,2517,9516,23
16,19−0,22−1,36 %16,4116,5715,62
16,45−0,41−2,49 %16,8617,2315,88
16,56−0,24−1,45 %16,8017,0116,32
16,810,100,59 %16,7117,1816,47
16,95−0,82−4,84 %17,7717,9916,93
18,030,291,61 %17,7418,5717,74
18,26−0,45−2,46 %18,7118,9018,24
18,83−0,44−2,34 %19,2719,4018,66
19,160,874,54 %18,2919,2018,16
18,300,000 %18,3018,5317,84
18,180,160,88 %18,0218,3117,55
18,450,442,38 %18,0118,9517,90
18,070,502,77 %17,5718,1617,37
17,49−0,29−1,66 %17,7818,1217,37
18,22−0,63−3,46 %18,8519,1818,20
18,910,211,11 %18,7018,9918,49
18,64−0,02−0,11 %18,6619,0518,43
18,66−0,68−3,64 %19,3419,3418,38
19,23−0,36−1,87 %19,5919,7619,03
19,46−0,40−2,06 %19,8620,2319,29
19,28−0,60−3,11 %19,8820,1219,16
18,75−0,31−1,65 %19,0619,1918,46
19,16−0,26−1,36 %19,4220,5018,55
18,74−1,26−6,72 %20,0020,1118,72
20,031,185,89 %18,8520,9818,08
20,99−0,45−2,14 %21,4422,3220,17
21,97−1,04−4,73 %23,0123,6121,35
22,640,441,94 %22,2023,1722,12
21,75−0,34−1,56 %22,0922,2021,25
22,931,185,15 %21,7525,4821,55
21,35−1,37−6,42 %22,7222,7821,14
22,65−0,37−1,63 %23,0223,1922,50
23,340,863,68 %22,4823,5722,39
22,290,010,04 %22,2822,6221,29
22,150,522,35 %21,6322,2521,61
21,430,542,52 %20,8921,4920,47
20,870,030,14 %20,8421,2720,64
20,49−0,28−1,37 %20,7720,9320,30
20,66−0,41−1,98 %21,0721,4320,57
21,160,170,8 %20,9922,2120,52
20,950,653,1 %20,3021,2919,99
20,260,120,59 %20,1420,3719,37
20,501,256,1 %19,2520,5519,22
19,150,110,57 %19,0419,3118,88
19,100,482,51 %18,6219,2118,06
18,89−0,41−2,17 %19,3019,9518,70
19,230,944,89 %18,2919,2918,19
18,090,331,82 %17,7618,5417,76
18,12−0,87−4,8 %18,9919,0918,01
18,94−0,08−0,42 %19,0219,1318,05
18,94−0,92−4,86 %19,8619,9718,58
18,600,824,41 %17,7818,7517,77
17,600,140,8 %17,4618,1016,34
18,82−0,64−3,4 %19,4619,5418,71
19,44−1,99−10,24 %21,4322,7819,10
25,981,706,54 %24,2826,4524,19
23,80−0,08−0,34 %23,8823,9823,05
23,52−0,30−1,28 %23,8224,2823,31
23,840,712,98 %23,1324,2023,09
23,70−0,67−2,83 %24,3724,3823,63
24,42−0,60−2,46 %25,0225,7424,29
24,80−1,43−5,77 %26,2326,3424,27
26,98−3,00−11,12 %29,9830,0326,25
26,270,070,27 %26,2026,4925,99
26,200,010,04 %26,1927,0025,80
26,010,271,04 %25,7426,3825,63
25,870,843,25 %25,0325,8924,77
25,35−0,28−1,1 %25,6325,8325,04
26,290,020,08 %26,2726,7325,32
26,690,200,75 %26,4927,4525,85
26,45−0,05−0,19 %26,5027,6426,38
26,870,461,71 %26,4127,8426,28
25,68−0,99−3,86 %26,6727,6524,20
28,25−0,50−1,77 %28,7529,3527,58
28,660,230,8 %28,4329,2528,20
28,07−0,15−0,53 %28,2228,5027,14
28,52−0,48−1,68 %29,0029,1328,17
29,130,080,27 %29,0530,9128,61
29,321,926,55 %27,4029,5626,91
27,071,214,47 %25,8627,4425,41
26,37−0,04−0,15 %26,4127,5026,12
26,66−0,33−1,24 %26,9927,6826,26
26,74−0,76−2,84 %27,5027,7326,50
27,45−1,26−4,59 %28,7128,7127,31
28,671,073,73 %27,6029,0627,27
27,57−0,73−2,65 %28,3028,3127,05
28,011,033,68 %26,9828,1526,57
26,54−0,24−0,9 %26,7826,9025,81
26,34−0,17−0,65 %26,5127,2426,23
26,20−1,71−6,53 %27,9128,1326,05
27,63−0,42−1,52 %28,0528,6027,24
28,273,2011,32 %25,0728,6225,01
24,36−1,02−4,19 %25,3825,5424,08
25,400,331,3 %25,0725,6124,63
25,00−0,42−1,68 %25,4225,7124,76
25,881,044,02 %24,8426,3324,27
24,741,345,42 %23,4025,0523,23
22,990,160,7 %22,8323,0222,16
22,61−0,95−4,2 %23,5623,6822,40
24,551,556,31 %23,0025,9420,49
22,621,386,1 %21,2422,8421,17
21,20−0,08−0,38 %21,2821,7620,62
21,280,512,4 %20,7721,3120,35
20,60−0,65−3,16 %21,2521,3120,49
21,320,080,38 %21,2421,6521,01
21,270,311,46 %20,9621,4520,33
20,920,180,86 %20,7421,8220,43
20,39−0,10−0,49 %20,4920,6019,48
20,560,401,95 %20,1620,6419,70
20,160,311,54 %19,8520,4719,66
19,850,140,71 %19,7120,3719,51
19,95−0,41−2,06 %20,3620,5919,74
19,780,371,87 %19,4120,0319,23
20,160,391,93 %19,7720,6619,26
19,58−1,87−9,55 %21,4522,1919,58
22,08−0,22−1 %22,3023,0321,77
21,560,572,64 %20,9921,8820,33
20,590,422,04 %20,1721,2019,82
19,730,150,76 %19,5820,2219,20
19,56−0,54−2,76 %20,1020,5019,25
20,622,2210,77 %18,4020,6717,32
17,72−0,99−5,59 %18,7118,9116,04
18,21−2,97−16,31 %21,1821,6218,01
26,21−0,17−0,65 %26,3827,0926,03
26,040,381,46 %25,6626,3525,07
25,64−0,63−2,46 %26,2726,9025,54
25,850,401,55 %25,4526,1625,12
25,770,180,7 %25,5926,4425,05
25,411,285,04 %24,1326,8523,89
24,390,753,08 %23,6424,4523,45
24,010,210,87 %23,8024,0222,85
23,870,733,06 %23,1423,9423,07
23,090,592,56 %22,5023,3421,75
22,75−1,75−7,69 %24,5025,0722,51
24,61−0,78−3,17 %25,3925,5024,21
25,261,897,48 %23,3725,3023,26
23,96−0,69−2,88 %24,6525,3323,48
24,650,170,69 %24,4825,7623,96
24,29−0,25−1,03 %24,5424,7223,83
24,20−2,80−11,57 %27,0027,0623,80
28,020,120,43 %27,9028,2726,73
27,902,007,17 %25,9029,9825,90
24,670,331,34 %24,3425,2123,42
24,121,144,73 %22,9824,3522,84
23,62−0,08−0,34 %23,7024,5323,20
24,11−0,31−1,29 %24,4226,9723,04
23,46−10,78−45,95 %34,2435,9222,24
36,703,7010,08 %33,0036,9132,48
33,233,9711,95 %29,2633,8528,56
27,351,666,07 %25,6927,5425,52
25,220,793,13 %24,4325,4624,25
24,611,656,7 %22,9624,9922,88
23,05−0,95−4,12 %24,0024,6022,21
24,62−1,56−6,34 %26,1826,2323,23
26,132,208,42 %23,9326,2322,84
23,243,0813,25 %20,1623,3120,16
20,152,3811,81 %17,7721,2417,76
18,231,9010,42 %16,3318,9015,79
16,64−1,33−7,99 %17,9718,0616,20
17,321,317,56 %16,0118,9015,55
17,36−0,74−4,26 %18,1018,4917,01
18,91−0,48−2,54 %19,3919,6418,54
20,461,969,58 %18,5020,5418,45
18,80−0,39−2,07 %19,1919,9018,61
19,29−0,51−2,64 %19,8019,8618,90
20,32−0,28−1,38 %20,6021,0720,14
20,600,542,62 %20,0620,7919,70
19,89−1,61−8,09 %21,5021,6919,56
20,24−0,37−1,83 %20,6120,6319,70
20,690,783,77 %19,9120,8219,63
19,750,321,62 %19,4320,0219,14
19,44−0,18−0,93 %19,6220,2119,39
20,110,331,64 %19,7820,2919,18
19,83−0,06−0,3 %19,8920,5319,16
20,13−0,69−3,43 %20,8220,8420,07
20,791,306,25 %19,4921,2919,20
19,19−0,60−3,13 %19,7920,5919,05
19,910,643,21 %19,2720,4519,27
18,500,603,24 %17,9018,8617,42
17,990,814,5 %17,1818,3916,55
17,78−1,06−5,96 %18,8418,9717,71
18,990,100,53 %18,8919,9218,51
19,550,643,27 %18,9119,5918,76
19,090,552,88 %18,5419,3718,34
19,13−1,67−8,73 %20,8021,3818,84
20,691,959,42 %18,7420,7218,50
18,49−0,11−0,59 %18,6019,2517,97
18,30−0,23−1,26 %18,5319,5518,27
18,11−1,08−5,96 %19,1919,2017,70
18,84−3,87−20,54 %22,7122,7118,52
22,12−1,68−7,59 %23,8024,1821,80
23,061,546,68 %21,5223,1121,42
21,600,612,82 %20,9921,6320,69
21,08−0,44−2,09 %21,5221,7220,43
21,37−0,76−3,56 %22,1322,1320,78
21,822,059,4 %19,7722,7319,46
19,570,874,45 %18,7019,6118,42
19,08−1,42−7,44 %20,5020,6318,90
20,50−0,07−0,34 %20,5721,5920,30
20,11−0,39−1,94 %20,5020,9519,85
20,67−0,20−0,97 %20,8721,4720,63
20,780,090,43 %20,6921,5620,43
20,620,623,01 %20,0020,8819,90
19,98−0,53−2,65 %20,5121,0019,83
21,50−1,42−6,6 %22,9222,9621,10
22,360,502,24 %21,8622,7621,56
21,64−1,74−8,04 %23,3823,8521,61
23,50−0,37−1,57 %23,8724,1722,81
23,520,984,17 %22,5423,5622,32
23,76−1,23−5,18 %24,9925,0023,40
24,651,656,69 %23,0025,0022,87
23,521,144,85 %22,3824,2122,38
22,102,8112,71 %19,2922,1119,28
19,030,512,68 %18,5219,3818,33
18,190,010,05 %18,1818,5017,68
18,200,935,11 %17,2718,2317,12
16,65−1,83−10,99 %18,4818,5716,46
18,170,673,69 %17,5018,3117,03
17,85−0,73−4,09 %18,5818,8616,73
18,820,371,97 %18,4519,3218,12
18,160,542,97 %17,6218,2017,37
17,47−0,92−5,27 %18,3918,4717,42
18,24−0,01−0,05 %18,2518,5518,06
18,350,382,07 %17,9718,8817,75
17,84−0,10−0,56 %17,9418,3117,17
17,890,000 %17,8918,1517,53
18,21−0,80−4,39 %19,0119,2217,98
19,280,532,75 %18,7519,5518,63
19,000,160,84 %18,8419,0818,33
18,670,693,7 %17,9818,9017,60

Susijusios diskusijos

Dflinx

praėjusią savaitę

What we thinking?

What we thinking?

Screwedontesla

prieš 2 savaites

New kid on the block(buster path)

Be careful people. This new combo looks better than Ivo in 1st line NSCLC: https://www.fiercepharma.com/pharma/merck-kelun-sac-tmt-adc-combo-beats-keytruda-65-progression-first-line-lung-cancer

LazyEyeStonk

praėjusį mėnesį

Hmmm, good entry ?

Squeezed hard, but support is around 16. You guys piling on still ?

Lolopolo

prieš 2 mėnesius

WOW

Holly short squeeze.

Lolopolo

prieš 2 mėnesius

Nobody here fr???

Ain't no way this community is dead. What's y'all gain?

Lolopolo

prieš 4 mėnesius

Fourth quarter and full-year 2025 financial results today

Y'all think Duggan gonna pull out smth unexpected data or collaboration on this conference call?

Lolopolo

prieš 5 mėnesius

anyone?

Helloooooooooooooooooo

NoRiskNoFun

prieš 8 mėnesius

Summit Therapeutics Q3 2025 earnings 📊

Summit Therapeutics Q3 2025 earnings 📊

Warrior8

prieš 11 mėnesių

Nice run today

Waiting for it hitting $32 again

Screwedontesla

prieš 11 mėnesių

Good luck all

This has been a beauty of a stock for me for the last 1.5 years (time flies!). Made close to 5 figures profit buying and selling over this time. I definitely could have made more but not perfect in trading for sure. Not saying this to brag but to show that if you REALLY know a company and can tie that to the stock market, you can make tons more than long term holding. This is a rarity tbh but it's possible for sure. With the rumours of a AZ "partnership", I think it's time to call it a day. Really not sure if it's true or what a final deal will look like but it will certainly curb max price. There's a tiny chance I jump back in if it drops and no deal is announced in the future. I will still try and get a job at SMMT IF they haven't sold UK/EU rights to someone! Hopefully it leads to mega profits for everyone still in 🍾

Aliraja

praėjusiais metais

Hi

Can it go 30£ ? I some time

Loser100

praėjusiais metais

Common

18 Billions cap ... Push it up

Loser100

praėjusiais metais

Why it's not growing

Everywhere I checked it has positive news but still not growing 😞🫣

Loser100

praėjusiais metais

Someone

Have any news about this stock... Please share

R14NCHOHAN

praėjusiais metais

Guys

Anyone else shorting?

Aliraja

praėjusiais metais

Hi

Anyone here what happened to this stock today.just bought at 23£

BetsKD

praėjusiais metais

Yay

Yay

drhaiderz

praėjusiais metais

I bought it here

I bought it here

BetsKD

praėjusiais metais

Painful

Painful Monday drop

BetsKD

prieš 2 metus

Woulda coulda

Every time I see this beautiful stock, I wish I'd stuck a few 1000 on 😅

Šiame puslapyje gali būti bendruomenės sukurto turinio, už kurį „Trading 212“ neatsako. Visada atlik savo tyrimą. „Trading 212“ teikia tik vykdymo paslaugą, bet neteikia investavimo konsultacijų ar portfelio valdymo paslaugų.

Investavimas be komisinių visiems

Pirk ir parduok Summit Therapeutics Inc +0,18 $ (1,28 %) ir daugiau nei 13 000 pasaulinių vertybinių popierių ir ETF

Gali būti taikomi kiti mokesčiai. Žr. mūsų sąlygas ir mokesčius.

Peržiūrėk mūsų sąlygas ir mokesčius čia

phone

Įsigyk vertybinių popierių iškart

Pasirink mėgstamiausią įmonę

Pasirink, kiek investuoti

Gauk akcijų per kelias sekundes

Turto kaupimas – įprotis.
Automatizuokite jį naudodami Pies.

Investuok į paruoštus arba susikurk savo investicijų rinkinius, pasirinkdamas iš daugybės vertybinių popierių ir ETF

Sužinok daugiau

Sužinok daugiau

Žiūrėti vaizdo įrašą

Turėk net brangiausių akcijų, tokių kaip „Google“, „Amazon“ ir „Apple“

Žiūrėti vaizdo įrašą

Peržiūrėk visas prekybos priemones

Pagalba visą parą

29 sekundžių vidutinis atsako laikas

Pradėk kaupti turtą jau dabar

Prisijunk prie daugiau nei 5 mln. naudotojų

Atsisiųsti programėlę

Atidaryti sąskaitą

Atsisiųsk mobiliąją programėlę

qr-code

Visi pateikti statistiniai duomenys yra globalūs. Klientų skaičius atspindi finansuotas sąskaitas.

Puiku

Įvertinta 4,6/5, remiantis 94 215 atsiliepimais apie

Trustpilot

Įvertinta 4,6/5, remiantis 94 215 atsiliepimais apie

Trustpilot

Pakviestas

Best % for £

Very easy to use. Best saving account.

Pakviestas

It’s made investing pretty easy..

It’s made investing pretty easy in fairness. It’s not made me a bunch of cash, but I can’t blame Trading 212 for that 😄 I chose risk, I won some, I lost some and I’m currently about Even Stevens, which's probably isn’t bad for my first few months trading while taking risks. It’s been a learning curve. You can take it sensibly and likely make small percentage profits, or you can be more of a gambler. I’m a risk taker, but I definitely need to be careful it doesn’t just become gambling. The app is good in that it warns you when you’re talking risks. And it’s trustworthy. I always feel completely trusting that my money is safe in terms of Trading 212 doing their bit well. I can’t ask for more than that 😊

Pakviestas

Great to watch your investment grow…

Great to watch your investment grow each day fab app

Pakviestas

The app is so user friendly and the…

The app is so user friendly and the interface is amazing 👏

Pakviestas

Best platform for new traders

Very easy to use. User friendly, best platform for new traders.

Pakviestas

Money transfer from Tading212 is Instantly

I have had no issues with them. I get regular updates on my interest I have 24x7 access to my money

Pakviestas

Easy to use

Easy to use. Incredibly understandable even for beginners for trading

Pakviestas

I like seeing daily interest

I like seeing daily interest. Much happiness very dopamine.

Pakviestas

Super easy to set up

Super easy to set up. The app shows your interest clearly. Definitely recommend

Pakviestas

User friendly app…

Really easy to set up and daily notifications so you can see how the interest is growing on your investment.

Pakviestas

great way to save my money

i live the idea of the daily interest it make me want to save more

Pakviestas

Very easy App to use

Very easy App to use. Good interest rate on cash ISA. It was simple signing up, and even easier to move funds into the new account. So far - so good! Very intuitive software. Excellent service all round, and my one query was answered quickly & efficiently! A 4.76% initial interest rate is excellent!!!

Pakviestas

Excellent and informative

Excellent and informative. Gives you an update daily on your interest. Very unlike my Bank did and I get a brilliant interest rate. I was told Trading 212 was excellent and I was not disappointed.

Pakviestas

User friendly such a good platform to…

User friendly such a good platform to invest

Pakviestas

All good

All good. I have not encountered any downsides so far.

Pakviestas

Financial discipline

I am able to cultivate a culture of discipline with trading 212

Pakviestas

Easy of use and clarity of information.

Easy of use and clarity of information.

Pakviestas

Easy to use app with very clear costs

Easy to use app with very clear costs

Pakviestas

Easy to set up a pie

Easy to set up a pie! Im new at this but still managed to do it.

Pakviestas

Amazing and practical app

Amazing and practical app - way better in functionality and customer support than other trading apps in Germany!

Pateikiami keli teigiami mūsų klientų atsiliepimai

Mūsų apdovanojimai

Dažniausiai užduodami klausimai

Kokia yra Summit Therapeutics (SMMT) akcijos kaina?

Dabartinė Summit Therapeutics (SMMT) kaina yra 14,29 $.

Koks yra SMMT52 savaičių maksimumas?

52 savaičių maksimumas SMMT yra 30,91 $.

Koks yra SMMT 52 savaičių žemiausias lygis?

52 savaičių žemiausias SMMT kursas yra 13,81 $.

Koks yra SMMT savaitės rezultatas?

Per pastarąją savaitę SMMT kaina pasikeitė −3,84 %.

Koks yra SMMT mėnesio našumas?

Per pastarąjį mėnesį SMMT kaina pasikeitė −20,96 %.

Koks yra SMMT 3 mėnesių rezultatas?

Per pastaruosius tris mėnesius SMMT kaina pasikeitė −5,43 %.

Koks yra SMMT 6 mėnesių rezultatas?

Per pastaruosius šešis mėnesius SMMT kaina pasikeitė −23,25 %.

Koks yra SMMTmetinis našumas?

Per pastaruosius metus SMMT kaina pasikeitė −30,6 %.